Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer

Objective: To evaluate the prognostic significance of preoperative DNA flow cytometry compared with other clinical and histologic variables in cervical carcinoma.

Study design: Sixty-four patients with FIGO Stage Ib-II cervical cancer treated with radical abdominal hysterectomy and systematic pelvic lymphadenectomy were analyzed. The mean follow-up was 3.4 (range 0.3-9.8) years. DNA flow cytometry was performed with fresh tumor tissue. Four biopsies were recut from the surgical specimen within 30 minutes of the operation. The ectocervix was divided into four quadrants and a specimen obtained from each. DNA-low-grade tumors (diploid, near-diploid, tetraploid and near-tetraploid) were distinguished from DNA-high-grade tumors (aneuploid and hypoploid). Carcinomas with more than one non-diploid stem line were considered heterogeneous. An S phase fraction >7% was classified as low, 7% - < 14% as moderate, and > or = 14 as high. DNA ploidy, DNA heterogeneity, S phase fraction and various clinical and histological variables were related to disease-free survival.

Results: In the univariate analysis patients with DNA-low-grade carcinomas had significantly better disease-free survival than patients with DNA-high-grade tumors (82% vs 45%, p = 0.021). Carcinomas with an S-phase fraction < 7% were associated with better disease-free survival (0.8) than those with an S-phase fraction 7% - > 14% (0.62) and those with > or = 14% (0.64), but this was not statistically significant. Cox stepwise regression analysis showed DNA-heterogeneity, age, grade, parametrial involvement and extrapelvic metastasis to be independent prognostic factors.

Conclusion: DNA ploidy and DNA heterogeneity are of prognostic importance in cervical cancer. DNA flow cytometry may be used preoperatively to identify low-risk and high-risk patients within a given stage.

Cervical cancer; Staging; DNA flow cytometry; Aneuploidy; Prognosis

[1] M. Anton, R. Menutil, A. Rejthar, J. Kopecny, B. Ptackova, J. Zaloudik: "DNA flow cytomet1y: a predictor of a high-risk group in cervical cancer". Cancer Detect. Prev., 1997, 21, 242.

[2] N. B. Atkin, B. M. Richards, A. Ross: "The deoxyribonucleic acid content of carcinoma of the uterus: an assessment of its possible significance in relation to histopathology and clinical course, based on data from 165 cases". Br. J. Cancer, 1959, 13, 773.

[3] N. B. Atkin: "Prognostic significance of ploidy level in human tumors: I. Carcinoma of the uterus". J. Natl. Cancer Inst., 1956, 56, 909.

[4] A. Bocking,C . P. Adler,H . H. Common,M . Hilgarth,B . Granzen, W. Auffermann: "Algorithm for a DNA-cytometric diagnosis and grading of malignancy". Anal. Quantitativ. Cytol., 1984, 6, 1.

[5] A. Bocking: "DNA Cytometry". In: "Surgical Gynecologic Oncology", E . Burghardt,M . J. Webb,J .M.M onaghan,G . Kindermann (eds.), Stuttgart, Thieme, 1993, 250.

[6] A. Bocking: "DNA measurments. When and why?". In: "Compendium on quality assurance, proficiency testing and workload limitations". In: "Tutorials of Cytology", G. L. Wied, C. M. Keebler, D. L. Rosenthal, U. Schenk, T. M. Somrak, G. P. Vooijs (eds.), Chicago, IL., Accademic press, 1995, 170.

[7] A. C. Broders: "Squamous cell epithelioma of the lip: a study of five hundred and thirty-seven cases". J.A.M.A., 1920, 74, 656.

[8] H. A. Casanova,M . Ohta,T . Kano,Y . Nishida, K. Sakakibara, T Ishihara, Y. Tomoda: "Prognostic significance of nuclear analysis in invasive carcinoma of cervix patients treated by primary radiation". Acta Obst. Gynaec. Jpn., 1986, 38, 243.

[9] J.P. Connor, D. S. Miller, K. D. Bauer, T. M. Murad, A. W. Rademaier, I. R. Lurain: "Flow-cytometric evaluation of early invasive cervical cancer". Obstet. Gynecol., 1993, 81, 367.

[10] J. R. Davis, S. Aristizabal,D . L. Way, S. A. Weiner,M . J. Hicks: "DNA ploidy, grade, and stage in prognosis of uterine cervical cancer". Gynecol. Oneal., 1989, 32, 4.

[11] J. E. D. Dyson, C. A. F. Joslin, R. I. Rothwell, P. Quirke, G. G Khourg, C. C. Bird： “Flow cytofluometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours". Radiother. Oncol., 1987, 8, 263.

[12] A. Fyles, P. Kirkbride: "Cervix uteri carcinoma". In: "Prognostic factors in cancer", P. Hermanek, M. K. Gospodarowicz, D. E Henson,R . V. P. Hutter,L . H. Sob (eds.),B erlin,S pringer,1995, 185.

[13] W. Goede, J. Schumann, J. Zaute: "The use of DAPI in pulse cytophotometry". In: "Pulse Cytophotometry", D. Lutz (ed.), European Press, Gent, 1978, 229.

[14] A. Goppinger,N . Freudenberg,A . Ross, G. H. Hillemans,M . Hi!garth: "The prognostic significance of DNA distribution in squamous cell carcinomas of the uterine cervix". Anal. Quant. Cytol. Histul., 1986, 8, 148.

[15] H. J. Grote, N. Friedrichs, N. Pomjanski, H. F. Guhde, 0. Reich, A. Bocking: "Prognostic significance of DNA cytornetry in carcinoma of the uterine cervix FIGO stage 1B and II". Anal. Quant. Cytol. Histol., 2001, 23, 97.

[16] D. Ireland, J. M. Monaghan: "A critical evaluation of three methods of studing cell proliferation in human cervical epithelium". Obstet. Gynecol., 1985, 65, 227.

[17] A. Jakobsen, P. Bichel,M . Vaeth: "New prognostic factors in squamous cell carcinoma of the cervix uteri". Am. J. Clin. Oneal., 1985, 8, 39.

[18] A. Jakobsen, P. Bichel, G. B. Kristinsen,M . Nylands: "Prognostic influence of ploidy level and histopathologic differentiation in cervical carcinoma stage lb". Eur. J. Cancer Clin. Oncol., 1988, 24, 969.

[19] G. G. Kenter, C. J. Cornelisse, E. J. Aartsen, W. Mooy, J. Hermans, A. P. M. Heintz, J. G. Fleuren: "DNA ploidy level as a prognostic factor in low stage carcinoma of the uterine cervix". Gynecol. Oneal., 1990, 39, 181.

[20] G. Kovacs: "Molecular differential pathology for renal tumours" Histopathology, 1993, 22, 1.

[21] G. B. Kristinsen, J. Kaern, V. M. Abeler, B. Hagrnar, C. G. Trope, E. O. Pettersen: "No prognsotic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients". Gynecol. Oneal., 1995, 57, 79.

[22] C. H. Lai,S . Hsueh,M . Y. Huang,M . F. Chang,Y . K. Soong: "The use and limitations of DNA flow cytornetry in stage 1B or II cervical carcinoma", Cancer, 1993, 72, 3655.

[23] C. H. Lai, J. H. Hong, S. Hsueh, K. W. Ng, T. C. Chang, C. J. Tseng et al.: "Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage 1B or II cervical carcinomas patients with or without pelvic lymph node metastases: an analysis of 891 cases". Cancer, 1999, 85, 1537.

[24] A. Leminen, J. Paavonen, E. Vesterinen,M . Forss,T . Wahlstrom, P. Kulomad,M . Lehtinen: "Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: Prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction". Am. J. Obstet. Gynecol., 1990, 162, 848.

[25] L. C. Lutgens, B. Schutte, J.M. De Jong, F. B. Thunissen: "DNA content as prognostic factor in cervical carcinoma stage lb-III treated with radiotherapy". Gynecol. Oncol., 1994, 54, 275.

[26] P. M. Magtibay, J. F. Perrone, R. Stanhope, J. A. Katzmann, G. L. Keeney, H. Li: "Flow-cytometric DNA analysis of early stage adenocarcinorna of the cervix". Gynecol. Oneal., 1999, 75, 20.

[27] T. Matsuyama,I . Inoue,N . Tsukamoto,M . Kashimura,T . Kamura, T. Saito, H. Uchino: "Stage IB, Ila and IIb cervical cancer, postsurgical staging, and prognosis". Cancer, 1984, 54, 3072.

[28] H. N. Nguyen, B. U. Sevin, H. E. Averette, H. E. Ganjei, P. Danjei J. Perras, R. Ramos, R. Angioli, D. Donato, M. Penalver: "The role of DNA index as a prognostic factor in early cervical carcinoma", Gynecol. Oneal., 1993, 50, 53.

[29] A. Onnis, T. Maggino,M . Marchetti: "Surgery as diagnostic and therapeutic moment in the management of cervical cancer". Eur. J. Gynecol. Oneal., 1985, 6, 20.

[30] D. H. Rutgers, P. M. van der Linden, H.A. van Peperzeel: "DNA flow cytometry of squamous cell carcinomas of the uterine cervix. The identification of prognostically different subgroups". Radiother. Oncol., 1986, 7, 249.

[31] R. E. Scully, T. A. Bonfiglio, R. J. Kurrnan, S. G. Silverberg, E. J Wilkinson: "Histologic Typing of Female Genital Tract Tumors". Berlin, Springer, 1994.

[32] P. Strang, U. Stendahl, R. Bergstrom, B. Frankendal, B. Tribuka: "Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patients". Gynecol. Oncol., 1991, 43, 3.

[33] R. Willen, C. Trope, E. Langstrom, J. Ranstam, D. Killandr, Clase: "Prospective malignancy grading and flow cytometry DNA distribution in biopsy speciemens from invasive squamous cell carcinoma of the uterine cervix". Anticancer Res., 1987, 7, 235.

[34] R. Willen, A. Himmelmann, E. Langstrom, M. Ferno, J. Ranstam, B. Baldetrop et al.: "Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix". Anticancer Res., 1993, 13, 1187.

[35] R. Winter: "Lymphadenectomy". In: "Surgical Gynecologic Oncology", E. Burghardt, M. J. Webb, J. M. Monaghan, G. Kindermann, (eds.), Stuttgart, Thieme, 1993, 182.

[36] T. C. W right, A. Ferenczy, R. Kurman: "Carcinoma and other tumors of the cervix". In: "Blaustein's Pathology of the Female Genital Tract", R. J. Kurman (ed.), New York, Springer, 2001, 325.

[37] J. M. Yu, H. Zhang, S. Q. Wang, H. Q. Miao, L. H. Yang, Y. T. Chen, G. D. Tian: "DNA ploidy analysis of effectiveness of radia­tion therapy for cervical carcinoma". Cancer, 1991, 68, 76.

[38] G. M. Zanetta, J. A. Katzmann, G. L. Keeney, W. K. Kinney, S. S Cha, K. C. Podratz: "Flow-cytometric DNA analysis of stages 1B and IIA cervical carcinoma". Gynecol. Oncol., 1992, 46, 13.